OVAXIN™ is a highly purified and inactivated vaccine that is manufactured using a vero cell manufacturing platform. Immune memory against conserved nucleoprotein may provide an added advantage over spike-only responses Memory T and B cells persisted for at least 6 months post vaccination Data suggest COVAXIN™ (BBV152) may provide protection against current and future variants